TipRanks (Fri, 3-May 2:02 AM ET)
Goldman Sachs Keeps Their Sell Rating on Envista Holdings (NVST)
TipRanks (Thu, 2-May 8:33 AM ET)
Envista Holdings (NVST) Receives a Buy from Stifel Nicolaus
TipRanks (Thu, 2-May 8:30 AM ET)
Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO) and Envista Holdings (NVST)
TipRanks (Thu, 2-May 6:40 AM ET)
Australia's March goods trade surplus narrows to more than 3-year low as imports jump
Seeking Alpha News (Thu, 2-May 2:44 AM ET)
Envista Non-GAAP EPS of $0.26 misses by $0.06, revenue of $623.6M misses by $10.9M
Seeking Alpha News (Wed, 1-May 4:17 PM ET)
Envista Reports First Quarter 2024 Results
PRNewswire (Wed, 1-May 4:10 PM ET)
Envista Q1 2024 Earnings Preview
Seeking Alpha News (Tue, 30-Apr 5:20 PM ET)
Envista Announces CEO Appointment
PRNewswire (Mon, 15-Apr 4:10 PM ET)
Envista Smile Project Donates $1.2 Million in 2023
PRNewswire (Thu, 11-Apr 4:10 PM ET)
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
Envista Holdings trades on the NYSE stock market under the symbol NVST.
As of May 3, 2024, NVST stock price declined to $19.00 with 1,999,465 million shares trading.
NVST has a beta of 0.53, meaning it tends to be less sensitive to market movements. NVST has a correlation of 0.05 to the broad based SPY ETF.
NVST has a market cap of $3.26 billion. This is considered a Mid Cap stock.
Last quarter Envista Holdings reported $624 million in Revenue and $.26 earnings per share. This fell short of revenue expectation by $-11 million and missed earnings estimates by -$.06.
In the last 3 years, NVST stock traded as high as $52.03 and as low as $18.09.
The top ETF exchange traded funds that NVST belongs to (by Net Assets): VTI, IJH, VB, VBR, VXF.
NVST has underperformed the market in the last year with a price return of -49.3% while the SPY ETF gained +26.1%. NVST has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -20.0% and -3.8%, respectively, while the SPY returned +3.7% and +2.4%, respectively.
NVST support price is $19.38 and resistance is $20.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVST stock will trade within this expected range on the day.